呼吸门控PET/CT用于肺部病变表征的前景与问题
本文综述了四维呼吸门控PET/CT在肺部病变表征中的证据。常规三维PET/CT因运动伪影导致病灶大小和代谢活性显示不准,呼吸门控旨在消除运动伪影影响,近期技术从硬件向软件方法转变,有望更广泛应用。
要点
- 常规三维胸部PET/CT易受运动伪影影响,导致病灶大小和代谢活性显示不准确。
- 呼吸门控(四维)PET/CT旨在消除运动伪影,更准确解读肺结节和淋巴结病变。
- 呼吸门控技术正从传统硬件向更简化的软件方法转变,未来有望更广泛应用。
核心结论
- 呼吸门控(四维)PET/CT旨在消除运动伪影,提供对肺结节和淋巴结病变更准确的解读,近期技术向软件方法转变有望促进其更广泛应用。
研究设计与样本
- 本文为综述,目的是回顾四维PET/CT在肺部病变表征方面的证据。
关键影像表现/征象
- 常规三维PET/CT成像胸部时易受运动伪影影响,使病灶信号模糊,导致大小和代谢活性显示不准确。
- 呼吸门控(四维)PET/CT旨在消除运动伪影的影响,提供对肺结节和淋巴结病变更准确的解读。
- 呼吸门控技术近期从传统硬件方法向更简化的软件方法转变。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
2-deoxy-2-(18Fluorine)-fluoro-D-glucose (FDG) PET/CT is an integral part of lung carcinoma staging and frequently used in the assessment of solitary pulmonary nodules. However, a limitation of conventional three-dimensional PET/CT when imaging the thorax is its susceptibility to motion artefact, which blurs the signal from the lesion resulting in inaccurate representation of size and metabolic activity. Respiratory gated (four-dimensional) PET/CT aims to negate the effects of motion artefact and provide a more accurate interpretation of pulmonary nodules and lymphadenopathy. There have been recent advances in technology and a shift from traditional hardware to more streamlined software methods for respiratory gating which should allow more widespread use of respiratory-gating in the future. The purpose of this article is to review the evidence surrounding four-dimensional PET/CT in pulmonary lesion characterisation.
引用
- Frood R, McDermott G, Scarsbrook A, et al. Respiratory-gated PET/CT for pulmonary lesion characterisation-promises and problems. Br J Radiol. 2018. PMID: 29338327. doi:10.1259/bjr.20170640
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。